Subchronic toxicity of Citrus aurantium L. (Rutaceae) extract and p-synephrine in mice
Introduction
Extracts of Citrus aurantium L. (Rutaceae) unripe fruits (syn.: zhi shi, green orange, sour orange and bitter orange) have been used for centuries in traditional Chinese medicine. Recently, they have gained significant popularity for the treatment of obesity, as an alternative to ephedrine alkaloids, which have been banned from dietary supplements by the United States Food and Drug Administration (FDA) in April 2004 due to an association with serious adverse health effects (Fugh-Bergman and Myers, 2004). The new products have been marketed as “ephedra free” and usually contain C. aurantium extracts standardized from 3% to 6% of p-synephrine (De Smet, 2004).
Chemically similar to ephedrine (from Ephedra spp., Ephedraceae) and amphetamine, p-synephrine also presents sympathomimetic activity which has been associated to a raise in metabolic rates and oxidation of fats through an increase in thermogenesis and lipolysis stimulation, presumably by means of β3-adrenoceptors. However, it has been demonstrated that this amine acts not only in β3-adrenoceptors, but also in β1, β2 and α-adrenoceptors (Fugh-Bergman and Myers, 2004). Consequently, several cardiovascular problems (e.g., hypertension, tachyarrhythmia, etc.) associated with the use of synephrine-containing products have been reported in animals (Calapai et al., 1999) and humans (Bouchard et al., 2005, Jordan et al., 2004, Nykamp et al., 2004, Firenzuoli et al., 2005, Haller and Benowitz, 2000, Bui et al., 2006, Gange et al., 2006). Previous studies of our group evaluated the acute toxicity of C. aurantium extract and p-synephrine, demonstrating an unspecific adrenergic stimulation and a transitory toxicity (Arbo et al., 2008) however, these products are consumed for a long period being important a subchronic evaluation.
On the other hand, amphetamines and analogues increase the production of free radicals and the pre-treatment with antioxidants attenuates the dopaminergic deficit inducted by amphetamine (Yamamoto and Zhu, 1998, Shankaran et al., 2001, Brown and Yamamoto, 2003). Evidences indicate that reactive oxygen species (ROS) direct or indirectly contribute to amphetamines mechanism of toxicity (Kovacic and Cooksy, 2005), and although the toxic effects caused by the abusive consumption of these substances have been known, the molecular factors that contribute to these effects are not completely understood (Frey et al., 2006). As part of the endogenous antioxidant system, there are the enzymes catalase (CAT), superoxide dismutase (SOD) and glutathione peroxidase (GPx). The SOD enzyme catalyzes the dismutation of the superoxide anion () in oxygen (O2) and hydrogen peroxide (H2O2). The H2O2 is not a free radical, but in high concentrations it can reacts with superoxide or iron (Fe2+) producing the highly reactive hydroxyl radical (OH−). The conversion of H2O2 to water (H2O) can be realized by CAT or GPx (Michiels et al., 1994). Indeed, GPx also catalyzes the reduction phospholipids-hydroperoxide and other organic hydroxyperoxides by glutathione (GSH), yielding oxidized glutathione (GSSG) which, in turn, is reduced back to GSH in a NADPH-dependent reaction catalyzed by glutathione reductase (GR). In this cycle, GSH acts as an immediate donor of electrons to neutralize the reactive species (Gul et al., 2000). Malondialdehyde (MDA) is one of the better-known secondary products of lipid peroxidation, and it can be used as an indicator of cell membrane injury (Esterbauer et al., 1991).
Due to the wide use of C. aurantium/p-synephrine-containing products and the relevance of its pharmacological and toxicological properties this research was undertaken to evaluate its subchronic toxicity in mice and their actions in oxidative stress biomarkers.
Section snippets
Chemicals
p-Synephrine (purity 99%) was purchased from M.P. Biomedical (Solon, Ohio, USA), 5-5′-dithio-bis(2-nitrobenzoic) acid was obtained from Sigma (St. Louis, MO, USA). HPLC grade acetonitrile, methanol and n-butanol were supplied by Tedia Company (Fairfield, USA). C. aurantium dried extract was obtained from Galena (Campinas, SP, Brazil). Water was purified using a Milli-Q system (Millipore, Bedford, USA). All the other chemicals used were of analytical grade.
Animals
Male albino CF1 mice weighting 42.57 ±
Results
The commercial extract of C. aurantium was submitted to qualitative and quantitative analyses through a previously validated HPLC/UV method (Arbo et al., 2008). p-Synephrine content was 7.5 ± 0.06%.
In the 28-day toxicity test, there were observed any clinical signs of toxicity, as well as no deaths occurred. Body weight did not change significantly during the treatment; however body weight gain was lower in groups treated with both doses of p-synephrine (Fig. 1). There were no changes in organs
Discussion
The content of p-synephrine in commercial C. aurantium extract analyzed was according to the marketed by the manufacturer, which should contain at least 6.0% p-synephrine. Usually, commercial extracts are standardized in 3–6% p-synephrine, however some products could contain until 90% p-synephrine and they are called special extracts (Avula et al., 2005).
Repeated-dose oral toxicity study of C. aurantium extract and p-synephrine in mice did not show any sign of toxicity, suggesting low
Conclusions
In this experimental work we evaluate the subchronic toxicity of C. aurantium extract and p-synephrine, which have been used in weight loss formulations. The results showed a decrease in weight gain after p-synephrine treatment and indicate for the tested materials a low subchronic toxicity in mice, moreover it was demonstrated that they can alter the oxidative metabolism. Regarding the lack of liver and kidney toxicity and the increasing of glutathione levels, it is possible to suggest a
Acknowledgments
We would like to thank Farmácia Calêndula for C. aurantium commercial extract donation and the technical assistance of Msc. Viviane de Moura Linck and Ana Paula Herrmann. This work was supported by CNPQ (Processo 478054/2006-8).
References (29)
Catalase in vitro
Methods Enzymol.
(1984)- et al.
Concentrations of p-synephrine in fruits and leaves of Citrus species (Rutaceae) and the acute toxicity testing of Citrus aurantium extract and p-synephrine
Food Chem. Toxicol.
(2008) - et al.
Ischemic stroke associated with use of an ephedra-free dietary supplement containing synephrine
Mayo Clin. Proc.
(2005) - et al.
Effects of amphetamines on mitochondrial function: role of free radicals and oxidative stress
Pharmacol. Ther.
(2003) - et al.
Antiobesity and cardiovascular toxic effects of Citrus aurantium extracts in the rat: a preliminary report
Fitoterapia
(1999) Tissue sulfhydryl groups
Arch. Biochem. Biophys.
(1959)- et al.
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
Free Radic. Biol. Med.
(1991) - et al.
Adverse reaction to an adrenergic herbal extract (Citrus aurantium)
Phytomedicine
(2005) - et al.
Increased oxidative stress in submitochondrial particles after chronic amphetamine exposure
Brain Res.
(2006) - et al.
Variant angina associated with bitter orange in a dietary supplement
Mayo Clin. Proc.
(2006)
Rapid quantification of malondialdehyde in plasma by high performance liquid chromatography-visible detection
J. Pharm. Biomed. Anal.
Anti-inflammatory effects and mechanisms of the ethanol extract of Evodia rutaecarpa and its bioactive components on neutrophils and microglial cells
Eur. J. Pharmacol.
Unifying mechanism for toxicity and addiction by abused drugs: electron transfer and reactive oxygen species
Med. Hypotheses
Superoxide dismutase, an enzymatic function for erythrocuprein (hemocuprein)
J. Biol. Chem.
Cited by (64)
Adipose and non-adipose perspectives of plant derived natural compounds for mitigation of obesity
2021, Journal of EthnopharmacologyTraditional medicinal knowledge of plants used for cancer treatment by communities of mountainous areas of Fez-Meknes-Morocco
2021, Saudi Pharmaceutical JournalAcridone alkaloids from the stem bark of Citrus aurantium display selective cytotoxicity against breast, liver, lung and prostate human carcinoma cells
2018, Journal of EthnopharmacologyCitation Excerpt :There have been conflicting reports concerning the safety of C. aurantium extracts and p-synephrine. While some studies associated the anti-obesity effects of C. aurantium with reduction of locomotor activity and cardiovascular toxicity in mice and rats (Calapai et al., 1999; Arbo et al., 2008, 2009), several clinical studies have shown that C. aurantium extract (at a dose of approximately 49 mg p-synephrine daily) displayed no adverse effects on the blood pressure, blood chemistries, electrocardiogram, heart rate, hepatic function and renal function (Kaats et al., 2013). Previous studies revealed that C. aurantium possesses several useful biological activities which are summarised in Table 1.
In vitro and in vivo evaluation of systemic and genetic toxicity of Citrus unshiu peel
2018, Journal of EthnopharmacologyCitation Excerpt :Several previous toxicological studies of different Citrus species-derived products have also been conducted. Arbo et al. (2009) demonstrated that 28-day oral administration of a methanolic extract of C. aurantium (up to 4000 mg/kg) in mice did not show any toxicological signs or lethality. Another study showed that a methanolic extract of C. macroptera Montr. (